Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Total Current Liabilities (2011 - 2026)

Lite Strategy (LITS) posted Total Current Liabilities of $952000.0 for Q1 2026, down 12.42% on a QoQ basis from $1.1 million in Q4 2025, and down 23.1% year-over-year from $1.2 million in Q1 2025.

Analysis

Lite Strategy (LITS) Total Current Liabilities (2011 - 2026) Analysis & Trends

Lite Strategy has reported Total Current Liabilities for 16 years, with the latest figure at $952000.0 in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 23.1% year-over-year to $952000.0 in Q1 2026; TTM through Mar 2026 was $952000.0, a 23.1% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 83.79% from the prior year.
  • Total Current Liabilities was $952000.0 for Q1 2026 at Lite Strategy, down from $1.1 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $24.4 million in Q2 2022, with the low at $952000.0 in Q1 2026.
  • Average Total Current Liabilities over 5 years is $10.8 million, with a median of $8.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities rose 20.94% in 2022, then slumped 87.13% in 2025.
  • Over 5 years, Total Current Liabilities stood at $22.7 million in 2022, then sank by 64.52% to $8.0 million in 2023, then sank by 71.55% to $2.3 million in 2024, then tumbled by 52.47% to $1.1 million in 2025, then fell by 12.42% to $952000.0 in 2026.
  • The last three Total Current Liabilities figures came in at $952000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - 952,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 952,000.00
Dec 31, 2025 1.09 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.24 Mn
Dec 31, 2024 2.29 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 8.36 Mn
Mar 31, 2024 9.62 Mn
Dec 31, 2023 8.04 Mn
Sep 30, 2023 8.56 Mn
Jun 30, 2023 20.34 Mn
Mar 31, 2023 23.62 Mn
Dec 31, 2022 22.65 Mn
Sep 30, 2022 23.44 Mn
Jun 30, 2022 24.44 Mn
Mar 31, 2022 23.96 Mn
Dec 31, 2021 22.67 Mn
Sep 30, 2021 20.84 Mn
Jun 30, 2021 20.21 Mn